Publications by authors named "Ghaith Nahar Alqudah"
Article Synopsis
- The study aimed to evaluate the effectiveness and safety of tislelizumab, a PD-1 inhibitor, in treating patients with malignant solid tumors.
- Researchers conducted a meta-analysis of seven phase III randomized controlled trials involving 3,478 patients, focusing on various outcomes like overall response rate (ORR) and overall survival (OS).
- Results showed that tislelizumab significantly improved both ORR and disease control rate (DCR), supporting its use as a treatment for malignant solid tumors.